expression and DAF-16 localization are unaffected by mdt-15 depletion or mutation. (A) mRNA fold change of skn-1 and daf-16 in mdt-15(RNAi) worms relative to control(RNAi) (n=4). mRNA levels were normalized to act-1, ama-1, cdc-42, and tba-1; error bars represent SEM. (B) Same as (A) but with N2 and mdt-15(rf) Fig. 2A ). mRNA levels were normalized to act-1, ama-1, cdc-42 and tba-1; error bars represent SEM. *Untreated worms differ significantly from control(RNAi) (p<0.05); † Treated worms differ significantly from control(RNAi) (p<0.05). Fold inductions of all arsenite-responsive genes are also shown (*p<0.05). (B) mRNA fold changes (relative to untreated N2) in N2 and mdt-15(rf) worms exposed acutely to 5 mM As (n=5). mRNA levels were normalized to act-1, ama-1, cdc-42 and tba-1; error bars represent SEM. **Untreated mutants differ significantly from N2 (p<0.01). † , † † Treated mutants differ significantly from N2 (p<0.05 and p<0.01 respectively). Fold inductions are also shown. *p<0.05. (C) mRNA fold changes (relative to untreated N2) in N2 and mdt-15(rf) worms exposed to 5 mM As for one hour (n=5). mRNA levels were normalized to act-1, tba-1 and ubc-2; error bars represent SEM. **Untreated mutants differ significantly from N2 (p<0.01). † , † † Treated mutants differ significantly from N2 (p<0.05 and p<0.01 respectively). Fold inductions are also shown. *,**p<0.05 and p<0.01 respectively. (D) Fluorescence micrographs showing gcs-1p::gfp worms grown to the L4 stage then treated with control or mdt-15 RNAi for 2 days. They were then either left untreated or acutely exposed to 5 mM arsenite. Table S5 .
(E) Same experiment as in (D), but with daf-2(e1368) mutants. For details, see Table S6 . Fig. S7. fat-6(tm331) ; fat-7(wa36) double mutants are not sensitive to tBOOH and fat-6 RNAi causes developmental defects.
(A) Survival plots of N2 and fat-6(tm331); fat-7(wa36) worms on 6 mM tBOOH. One representative experiment out of three independent repeats is shown. For details see Table S2 . (B) DIC micrographs of N2 worms grown to the L4 stage on control, mdt-15 and fat-6 RNAi.
